Here - American Geriatrics Society
Here - American Geriatrics Society
Here - American Geriatrics Society
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
P OSTER<br />
A BSTRACTS<br />
The diagnosis of Alzheimer’s disease (AD) and normal pressure<br />
hydrocephalus (NPH), as several neurodegenerative diseases, mainly<br />
based on clinical examination, neuropsychological assessment and<br />
conventional imaging, remains difficult.<br />
The aim of this study is to demonstrate the role of Phase-contrast<br />
magnetic resonance imaging (PC-MRI) in the assessment of<br />
cerebral flows, and in consequence in the differential diagnosis between<br />
AD and NPH.<br />
Materials and methods:<br />
Our population consisted of 20 AD patients (mean age: 80 ± 5<br />
years) and 13 NPH (mean age: 70 ± 6 years). Patients were categorized<br />
during a special consultation by a neuropsychologist and a geriatrician.<br />
All the patients underwent cerebral MRI using a 3T-scanner including<br />
PC-MRI imaging for CSF and blood flows quantification.<br />
They were compared with a population (n = 12) of age-matched<br />
healthy elderly (HE) (mean age: 71 ± 9 years) with normal neurological<br />
and neuropsychological screening results (MMSE).<br />
PC-MRI acquisition was then performed in addition of classical<br />
morphological sequences. The PC-MRI sections were positioned at<br />
the cervical level to investigate cerebral vascular input flows from internal<br />
carotids and vertebral vessels. PC-MRI was also performed at<br />
the aqueductal and cervical levels to measure the CSF flows. Afterwards,<br />
PC-MRI images were analyzed to calculate global arterial flow<br />
curves during cardiac cycle (cc). NPH, MA, HE populations were<br />
compared.<br />
Results:<br />
There was no statistical difference of the mean arterial CBF between<br />
the 3 groups (in ml/min): MA (495 ± 84), NPH (450 ± 129) and<br />
HE (509 ± 108).<br />
Cervical CSF flow analysis showed also similar values for all<br />
3 groups (in μl/cc): MA (530 ± 210), NPH (455 ± 133) and HE<br />
(457 ± 154).<br />
In contrast, NPH presented significantly the highest aqueductal<br />
CSF stroke volume (167 μl/cc ± 89) compared to AD (50 ± 30) and<br />
HE (34 ± 17) (P < 0, 05).<br />
Conclusion:<br />
CSF flows quantification can be helpful for aetiological and differential<br />
diagnosis between AD and NPH, especially in case of enlargement<br />
of lateral ventricles.<br />
D26<br />
The First Intervention Study in Elder Self-Neglect: A Randomized<br />
Clinical Trial to Improve Vitamin D Levels.<br />
J. Burnett, 1,4 A. E. Hochschild, 1,4 S. M. Smith, 2,4 A. L. Stotts, 1,4<br />
P. M. Diamond, 3,4 C. B. Dyer. 1,4 1. Internal Medicine, UT Health,<br />
Houston, TX; 2. National Aeronautics and Space Administration<br />
(NASA), Houston, TX; 3. Health Promotoin and Behavioral Sciences,<br />
UT, School of Public Health, Houston, TX; 4. Texas Elder Abuse and<br />
Mistreatment Institute (TEAM), Houston, TX.<br />
Supported By: The National Institute on Aging. Grant # 1R21<br />
AG033261-01A1<br />
Background: Despite high mortality rates, elder self-neglect is<br />
characterized by refusal of medical and social interventions. To date<br />
there have been no tested clinical interventions in elders who selfneglect.<br />
Previous TEAM Institute research has shown significantly<br />
low vitamin D levels in this population. This study aimed to determine<br />
the feasibility of a clinical intervention. Replacement of vitamin<br />
D was chosen because of its ease of administration and favorable<br />
safety profile. Methods: A randomized clinical trial using directly observed<br />
therapy of vitamin D was conducted using 50 elders, >65 years<br />
of age, with Adult Protective Services (APS) validated self-neglect. A<br />
staggered intervention with waiting controls was used to maximize<br />
statistical power. One-third (n=17) of the group was administered<br />
50,000 IU vitamin D2 (ergocalciferol) monthly and the remainder<br />
(n=33) were administered 400 IU monthly. Serum 25-OH vitamin D<br />
was assessed at baseline and 5-months. Results: 69% agreed to participate<br />
in the study and of those n=40 (80%) remained at 5-months. At<br />
baseline, 12% (n=7) were deficient in vitamin D (